Literature DB >> 19902149

Impact on patient care: patient case through the continuum of care.

Scott Kaatz1.   

Abstract

Hospitalized patients are at increased risk of venous thromboembolism and the Joint Commission has initiated practice measures to improve the rates of preventable events. The Joint Commission also initiated the National Patient Safety Goals for medication prescribing and administration, of which, goal 03.05.01 is specifically aimed at anticoagulation therapy. These measures and goals are consistent with the American College of Chest Physicians' Consensus Guidelines on Antithrombotic and Thrombolytic Therapy. This narrative review uses a case-based approach that brings up practical clinical questions regarding these measures, goals and guidelines as they apply to a patient going through the continuum of care from the hospital to their home.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19902149     DOI: 10.1007/s11239-009-0408-1

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  14 in total

1.  Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients.

Authors:  Francesco Dentali; James D Douketis; Monica Gianni; Wendy Lim; Mark A Crowther
Journal:  Ann Intern Med       Date:  2007-02-20       Impact factor: 25.391

2.  A randomized trial comparing 5-mg and 10-mg warfarin loading doses.

Authors:  M A Crowther; J B Ginsberg; C Kearon; L Harrison; J Johnson; M P Massicotte; J Hirsh
Journal:  Arch Intern Med       Date:  1999-01-11

Review 3.  Effect of study setting on anticoagulation control: a systematic review and metaregression.

Authors:  Carl van Walraven; Alison Jennings; Natalie Oake; Dean Fergusson; Alan J Forster
Journal:  Chest       Date:  2006-05       Impact factor: 9.410

4.  Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism.

Authors:  Victor F Tapson; Hervé Decousus; Mario Pini; Beng H Chong; James B Froehlich; Manuel Monreal; Alex C Spyropoulos; Geno J Merli; Rainer B Zotz; Jean-François Bergmann; Ricardo Pavanello; Alexander G G Turpie; Mashio Nakamura; Franco Piovella; Ajay K Kakkar; Frederick A Spencer; Gordon Fitzgerald; Frederick A Anderson
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

5.  Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: results of the managing anticoagulation services trial.

Authors:  David B Matchar; Gregory P Samsa; Stuart J Cohen; Eugene Z Oddone; Annette E Jurgelski
Journal:  Am J Med       Date:  2002-07       Impact factor: 4.965

6.  Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  William H Geerts; David Bergqvist; Graham F Pineo; John A Heit; Charles M Samama; Michael R Lassen; Clifford W Colwell
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

7.  Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Theodore E Warkentin; Andreas Greinacher; Andreas Koster; A Michael Lincoff
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

8.  Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Clive Kearon; Susan R Kahn; Giancarlo Agnelli; Samuel Goldhaber; Gary E Raskob; Anthony J Comerota
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

9.  Clinical assessment of venous thromboembolic risk in surgical patients.

Authors:  J A Caprini; J I Arcelus; J H Hasty; A C Tamhane; F Fabrega
Journal:  Semin Thromb Hemost       Date:  1991       Impact factor: 4.180

10.  Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.

Authors:  Susan R Kahn; Akbar Panju; William Geerts; Graham F Pineo; Louis Desjardins; Alexander G G Turpie; Stanislav Glezer; Lehana Thabane; Rolf J Sebaldt
Journal:  Thromb Res       Date:  2006-03-03       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.